Down-staging ( (6) Beukers, Willemien a Meijer, Titia a Vissers, Cornelis J a Boormans, Joost L b Zwarthoff, Ellen C a Van Leenders, Geert J L H a a JOSEPHINE NEFKENS INSTITUTE (Netherlands) b ERASMUS MEDICAL CENTER (Netherlands)

Virchows Archiv

Volumn 461, Issue 2, 2012, Pages 149-156

Author keywords

Cystectomy; Down staging; pT0; Urothelial cell carcinoma

Indexed keywords

DESMIN;

ADULT; AGED; ARTICLE; BLADDER DISEASE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE SPECIFIC SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCULUS DETRUSOR INVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM GRADING; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 84867403770     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1277-0     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96 (Pubitemid 351521864)
2. Colombel M, Akaza H, Bohle A, Palou J, Buckley R, Lamm D, Brausi M, Witjes JA, Persad R (2008) Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl 7:618-626
3. Morgan TM, Keegan KA, Clark PE (2011) Bladder cancer. Curr Opin Oncol 23:275-282
4. Ghoneim MA, Abdel-Latif M, El-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, El-Baz MA (2008) Radical cystectomy for carcinoma of the bladder: 2, 720 consecutive cases 5 years later. J Urol 180:121-127
5. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414-2422 (Pubitemid 44755069)
6. Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H, Reuter V (2001) Cystectomy for bladder cancer: a contemporary series. J Urol 165:1111-1116 (Pubitemid 32210214)
7. Lee SE, Jeong IG, Ku JH, Kwak C, Lee E, Jeong JS (2004) Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor. Urology 63:873-877 (Pubitemid 38596668)
8. Amling CL, Thrasher JB, Frazier HA, Dodge RK, Robertson JE, Paulson DF (1994) Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151:31-35
9. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666-675 (Pubitemid 32120143)
10. Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP (2011) Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 107:898-904
11. Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Ogreid P (2003) Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 169:1291-1294 (Pubitemid 36323769)
12. Ro JY, Ayala AG, El-Naggar A (1987) Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 11:668-673 (Pubitemid 17148465)
13. Miyamoto H, Sharma RB, Illei PB, Epstein JI (2010) Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma. Am J Surg Pathol 34:418-422
14. Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB (2010) Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol 34:792-799
15. Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB (2009) Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 33:91-98
16. Cheng L, Montironi R, Davidson DD, Lopez-Beltran A (2009) Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 22:S70-S95
17. Council L, Hameed O (2009) Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma. Mod Pathol 22:639-650
18. Thrasher JB, Frazier HA, Robertson JE, Paulson DF (1994) Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol 152:393-396
19. Volkmer BG, Kuefer R, Bartsch G Jr, Straub M, De Petriconi R, Gschwend JE, Hautmann RE (2005) Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 104:2384-2391 (Pubitemid 41691559)
20. Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4, 430 patients. J Urol 184:888-894
21. Herr HW (2001) Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19:89-93 (Pubitemid 32063483)
22. Morgan TM, Clark PE (2010) Bladder cancer. Curr Opin Oncol 22:242-249